New MRI method aims to spot kidney trouble early in metabolic syndrome
NCT ID NCT06407375
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special type of MRI (multiparametric MRI) can reliably measure kidney function in people with metabolic syndrome—a cluster of conditions like obesity, high blood pressure, and high blood sugar. Researchers compared MRI results between 46 healthy volunteers and people with metabolic syndrome to see if the scan could detect early kidney damage before standard tests show problems. The goal was to explore the MRI's accuracy and usefulness, not to provide a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Seaweed extract may tackle fatty liver Disease—A trial puts it to the test
- Ancient herb huangjing put to the test against hidden belly fat
- Can a damaged kidney change how antibiotics work?
- Lifestyle overhaul may restore penile blood flow in metabolic syndrome
- Can a Plant-Based protein switch reshape your metabolism?
- Plant protein drink may shield aging Hearts—A trial puts it to the test